Global antimicrobial fund expands with USD 140m and CEO

The Wellcome Trust, the EIB and the Boehringer Ingelheim Foundation now financially support the work of the AMR Action Fund.

Photo: Peter Klint

Less than a year after the AMR Action Fund addressing antimicrobial resistance was founded with financial support from the pharmaceutical industry, the fund has raised more capital.

The Wellcome Trust, the European Investment Bank and the Boehringer Ingelheim Foundation have posted USD 140m into this work. The money is added onto the billion dollars with which the fund set out in July last year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs